Polymer bioconjugation offers powerful strategies to extend half-life, improve stability, and enable encapsulation of therapeutic molecules. By conjugating polymers to proteins, peptides, or other actives, it is possible to enhance pharmacokinetics, reduce immunogenicity, and unlock new delivery pathways. At Curapath, we design and supply custom polymer conjugates, leveraging advanced chemistries to provide optimized shielding, controlled release, and targeted delivery solutions tailored to each project.
